Innovation Committee

The Innovation Committee was created in 2020 and assists the Board of Directors with the review of Novozymes’ overall capabilities and strategic direction in matters of technology, science and innovation. The Innovation Committee held its inaugural meeting in 2020, where focus was on the corporate innovation pipeline and on the innovation strategy for the OneHealth brand.

The Innovation Committee consists of three members, who are members of the Board of Directors.

The following members have been elected to the Innovation Committee by the Board of Directors:

  • Sharon James (Chair)
  • Kim Stratton
  • Mathias Uhlén

The Charter of the Innovation Committee can be found here.